New drug combo trial aims to boost fight against aggressive nasal cancer
NCT ID NCT04004871
Summary
This study tested whether a new three-drug chemotherapy combination (APF) given before standard radiation and chemo could better control advanced nasopharyngeal cancer. It involved 60 patients in China with newly diagnosed, locally advanced disease that had not spread. The goal was to see if this approach was safe and more effective at shrinking tumors and preventing cancer return.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NASOPHARYNGEAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, 530021, China
Conditions
Explore the condition pages connected to this study.